WALTHAM, MA--(MARKET WIRE)--Sep 5, 2007 -- EyeGate Pharma, a privately held, specialty pharmaceutical company pioneering the use of iontophoresis technology to safely and non-invasively deliver therapeutics for ocular indications, today announced that the company is a corporate sponsor of the 9th Congress of the International Ocular Inflammation Society (IOIS), which will be held in Paris, France, at the Meridien Etoile Hotel from September 17 - 20, 2007.
